3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Hematologic Neoplasms
4
Smoking Cessation
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Ovarian Neoplasms
1
Neoplasms
1
Mental Disorders
1
Lung Neoplasms
1
Hematopoietic and Lymphoid System Neoplasm
1
Hematopoietic and Lymphatic System Neoplasm
1
Head and Neck Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Advanced Malignant Solid Neoplasm
1
Interventions
Gemcitabine
31
Cisplatin
22
pembrolizumab
21
Magnetic Resonance Spectroscopy
18
Specimen Handling
16
durvalumab
11
Mitomycin
10
enfortumab vedotin
9
avelumab
9
Cystoscopy
9
Nivolumab
8
Fluorouracil
8
Carboplatin
8
Radiation
7
Cystectomy
7
atezolizumab
5
Transurethral Resection of Bladder
5
Radiotherapy
5
Mitozytrex
5
Immunoglobulin G
5
Docetaxel
5
Disulfides
5
Biopsy
5
tremelimumab
4
sacituzumab govitecan
4
erdafitinib
4
dehydroftorafur
4
Platinum
4
1,2-diaminocyclohexaneplatinum II citrate
4
disitamab vedotin
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Urinary Bladder Neoplasms
×
Behavior Therapy
×
90 days
×
Clear all
No trials found.